THRU ONLINE FILING

April 24, 2019

BSE Limited Phiroze Jeejeebhoy Towers 27'h Floor, Dalal Street Mumbai 400 023

The National Stock Exchange of India Ltd. Exchange Plaza, 5 thFir, Plot # C/1 G Block, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051

Dear Sirs,

Re: Acquisition of 100% paid-up share capital of Ramdev Chemical Private Liniited

We are pleased to inform you that the Company has entered into a Share Purchase Agreement (SPA) to acquire 100% paid-up share capital of Ramdev Chemical Private Limited, a company incorporated in 1999 under Companies Act, 1956 and engaged in the business of manufacturing and marketing of advanced drug intermediates, fine chemicals, custom synthesis molecules and active pharmaceutical ingredients for cash @ Rs. 108.50 crores.

The required disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed herewith.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish P. Kam.ath Corporate Counsel & Company Secretary

Encl: a/a

Ipea Laboratories Ltd.

www.ipca.com

125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067, India I T: +91 2262105000 F:+91 2262105005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400067, India I T: +91 2266474444 F:+91 22 28686613 E:[email protected] I ClN: L24239MH1949PLC007837

DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015

Acquisition of 100% paid-up share capital of Ramdev Chemical Pvt. Ltd. (RCPL)

8.	Name ofthetargetentity, detailsin brief	RamdevChemicalPvt. Ltd. (RCPL)
	such as size, turnoveretc	E41, 6129,MIDC IndustrialArea,E128/2,
		Tarapur,Boisar,District Palghar-401506
		3151 MarchFor the financialyear ended2019
		(unaudited-ManagementCertified):
		Income: Rs. 75.89 crores
		EBIDTA: Rs.9.18 crores
		Profit After Tax:Rs.3.01 crores"
b.	Whetherthe acquisitionwould fall withinrelatedparty transaction(s)and whetherthe promoterlpromotergrouplgroupcompanieshave any interestin theentity being acquired?If yes, nature ofinterestand details thereofand whetherthe same is done at "arms length"	This acquisitiondoes not fall within therelatedparty transactionand the promoter1 promotergrouplgroup companieshave no interestin theentity being acquired.
c.	Industry to which the entity beingacquiredbelongs	RCPLisengagedinthebusinessofmanufacturingandmarketingofadvanceddrugintermediates,finechemicals,customsynthesismoleculesandactivepharmaceuticalingredients(APls)(Colleetivelyreferredto as Products).
d.	Objectsand effectsof acquisition(includingbut not limited to, disclosureof reasonsfor acquisitionof targetentity,if its businessis outsidethe mainline of businessof the listed entity)	The acquisitionof RCPLwilihelp the Companytogrow its API businessby addingnew moleculesinits Productsbasket with possibilityof forwardintegratingsuch Productsin its dosageformulationsbusinessfor the worldmarket.
e.	Brief detailsof any governmentalorregulatoryapprovalsrequiredfor theacquisition	Prior governmentalor regulatoryapprovalis notrequiredfor this acquisition.
f.	Indicativetime period for completionofthe acquisition	This acquisitionis as per Share Purchaseon 24th April,Agreementsigned2019.
g.	Natureof consideration- whethercashconsiderationor share swap and detailsof the same	Cash Considerationof Rs. 108.50 crores.
h.	Cost of acquisitionor the price at whichthe sharesare acquired	Cash Considerationof Rs. 108.50croresfor theacquisitionof 100% shareholdingof RCPL.
i.	Percentageof shareholding1controlacquiredand lornumberof sharesacquired	100% of the shareholdingof the targetentity isbeing acquired.

www.ipca.com 125, Kandivli Industrial Estate, CTS No. 328, Kandivli (West), Mumbai 400 067, India I"T: +91 2262105000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067, India I T: +91 22 6647 4444 F: +91 22 2868 6613 E: [email protected] I ClN: L24239MH1949PLC007837

		.:<':
j.	Brief backgroundabout the entityacquiredin terms of products/lineof businessacquired,date ofincorporation,history of last 3 yearsturnover,countryin which theacquiredentity has presenceandany other significantinformation(in	M/s.RamdevChemicalPvt.Ltd.(RCPL),a companyincorporatedin1999underCompaniesAct,1956isengagedinthebusiness.ofmanufacturingandmarketing,ofadvanceddrugintermediates,finechemicals,customsynthesismoleculesandactivepharmaceuticalingredients(APls).
	brief)	Theregisteredofficeandmanufacturingunitofthecompanyis locatedat MIDC,Boisar,District -Palghar,Maharashtraonleaseholdlandadmeasuringabout16,000 sq. metres with constructedarea of about5600sq metres.The manufacturingfacilityof the companyisinspectedamongstothersby US FDA and EDQM.
		31sl.CertifiedRs.	March,2019Accounts),the75.89crores,and Profit after tax of
		TheProductsof thecompanyareexportedtomanycountriesacrossthe globeincludingUSA, U.K., Japan,GermanyandCanada.Theclienteleof thecompanyincludesmajorIndianpharmacompaniesaswellasseveralmultinationalcompanies.Thecompanyhasemployeestrengthofaround170well qualifiedand trainedstaff.Thecompanyalsohasafullyequipped.R&Dcentreatitsmanufacturingfacility.

		3151 March)(Financialyear ended(Rs. Crores)
			2019(Unaudited)	2018(Audited)	2017.(Audited)	2016(Audited)
		Total Income	75.8974.68		72.32	68.87
		EBIDTA	9.18	10.06	9.49	11.43
		Depreciation	4.60	4.31	3.73	3.38
		FinanceCost	0.46	0.32	0.09	0.22
		Profit beforeTax	4.12	5.43	5.67	7.83
		Tax Expense	1.11	1.83	1.79	2.61
		Profit afterTax	3.01	3.60	3.88	5.22